Investor Presentaiton

Department of Health Notes to the financial statements For the year ended on 30 June 2023 8.1 Financial risk management (continued) d) Liquidity risk and Interest rate exposure (continued) Interest rate exposure and maturity analysis of financial assets and financial liabilities Weighted average effective Interest rate exposure 2022 Financial Assets Cash and cash equivalents Maturity dates interest Carrying Fixed interest Variable interest Non- interest More rate % amount $'000 rate $'000 rate $'000 bearing $'000 Nominal amount $'000 Up to 1 month 1 to 3 3 months 1 to 5 than 5 months to 1 year years years $'000 $'000 $'000 $'000 $'000 128,508 128,508 128,508 128,508 Restricted cash and cash equivalents 123,619 123,619 123,619 123,619 Receivables (a) 42,778 42,778 42,778 22,113 1,422 17,294 1,949 Amounts receivable for services 93,690 93,690 93,690 388,595 388,595 388,595 274,240 1,422 17,294 1,949 93,690 93,690 Financial Liabilities Payables 149,578 149,578 Lease liabilities (b) 2.50 2,317 151,895 2,317 2,317 149,578 2,317 126,794 15 3,968 51 18,363 444 453 1,702 105 149,578 151,895 126,809 4,019 18,807 2,155 105 (a) The amount of receivables excludes the GST receivable from the ATO (statutory receivable). (b) The amount of lease liabilities includes $2.1 million from leased buildings and $0.2 million from leased vehicles. e) Interest rates sensitivity analysis The department's financial assets and liabilities were not subject to interest rate sensitivity at the end of the current and previous period. 8.2 Contingent assets and liabilities Contingent assets and contingent liabilities are not recognised in the statement of financial position but are disclosed and, if quantifiable, are measured at the best estimate. Contingent assets and liabilities are presented inclusive of GST receivable or payable respectively. < 183 > Contents About us Significant issues Report on operations Agency performance Operational disclosures Key performance indicators Financial disclosures and compliance • Appendix

View entire presentation